Malaysia government approves intellectual property patent of SR-T100 for treatment of anti-wart (genital warts and common warts) pharmaceutical composition and method

G&E had submitted the applications for intellectual property patents of SR-T100 to more than 30 nations including Taiwan, USA, European Union, China, Japan, Korea and South Africa etc. Among these countries, Taiwan, Japan, South Africa, New Zealand, Australia, Singapore, European Union, China and Malaysia have approved SR-T100 application of “Anti-Wart Pharmaceutical Composition and Method for Treating Wart.”